Key facts
- Srotas Health’s last known valuation is $3.3M (Feb 2025).
- It has raised $340K; the latest was Accelerator/Incubator in Apr 2025.
- Notable investors include SFC Capital, MaRS Discovery District, DigitalHealth.London Accelerator, lablab NEXT.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Srotas Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Srotas Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Srotas Health
Developer of a healthcare platform designed to accelerate clinical trials and improve patient care in oncology. The company's platform integrates generative artificial intelligence to streamline trial processes, enhance data analysis, and optimize treatment pathways, enabling researchers and healthcare providers to conduct studies more efficiently, reduce time to market for new therapies, and improve outcomes for patients through advanced biomedical insights.
- Sector
- Healthcare
- HQ
- Holywood, United Kingdom
- Founded
- 2022
- Employees
- 10
- Website
- srotas.health/
- Ownership
- Privately Held (backing)
Srotas Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Srotas Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Srotas Health in its N-PORT filings yet. We sweep new filings monthly.